Beiersdorf Aktiengesellschaft (OTCMKTS:BDRFF) Given Consensus Recommendation of “Reduce” by Brokerages

Beiersdorf Aktiengesellschaft (OTCMKTS:BDRFF) has been assigned a consensus recommendation of “Reduce” from the six ratings firms that are currently covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation and four have given a hold recommendation to the company.

Several brokerages recently issued reports on BDRFF. Royal Bank Of Canada lowered shares of Beiersdorf Aktiengesellschaft from a “sector perform” rating to an “underperform” rating in a research note on Tuesday, March 10th. Berenberg Bank reissued a “hold” rating on shares of Beiersdorf Aktiengesellschaft in a research note on Monday, March 23rd. UBS Group raised shares of Beiersdorf Aktiengesellschaft from a “sell” rating to a “neutral” rating in a research note on Tuesday, March 31st. JPMorgan Chase & Co. reissued a “neutral” rating on shares of Beiersdorf Aktiengesellschaft in a research note on Wednesday, March 18th. Finally, Morgan Stanley lowered shares of Beiersdorf Aktiengesellschaft from an “equal weight” rating to an “underweight” rating in a research note on Monday, March 16th.

Beiersdorf Aktiengesellschaft Price Performance

Shares of OTCMKTS BDRFF opened at $82.99 on Wednesday. Beiersdorf Aktiengesellschaft has a 12-month low of $81.25 and a 12-month high of $135.52. The company’s fifty day simple moving average is $85.76 and its 200 day simple moving average is $100.61.

About Beiersdorf Aktiengesellschaft

Beiersdorf Aktiengesellschaft is a global consumer goods company headquartered in Hamburg, Germany, with a history dating back to its founding in 1882 by pharmacist Paul C. Beiersdorf. The company is best known for its skincare brands, including NIVEA, Eucerin, La Prairie and Labello, as well as its tesa division, which produces self-adhesive products and industrial tapes. Over its long history, Beiersdorf has built a reputation for innovation in dermatological research and product development, introducing pioneering formulations that span mass-market and premium segments.

The company’s operations are organized into two main business divisions.